FTC files lawsuit against top PBMs and GPOs for alleged anticompetitive practices in inflating insulin prices. Learn about the allegations and responses.
No, if Novo Nordisk lowered their list price for Ozempic and Wegovy tomorrow to a price that was the same or lower than current net cost, that change by itself would not result in less favorable ...